Bortezomib vs no bortezomibHealth‐related quality of life · All patients with a diagnosis of multiple myeloma1 finding from 1 reviewBortezomib for the treatment of multiple myeloma 2016 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 717 participantsGRADE not reported